← FDA DRUG APPROVALS

FDA NDA · NDA022223

TRIESENCE

Sponsor: ALCON RES

APPLICATION
NDA022223
TYPE
NDA
ORIGINAL APPROVAL
2007-11-29
LATEST ACTION
2007-11-29
ROUTE
SUSPENSION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TRIESENCEPrescription
TRIAMCINOLONE ACETONIDE 40MGML · INJECTABLE · SUSPENSION

Approval history

2007-11-29Type 6 - New Indication (no longer used) · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →